Want to see INBS full AI Analyst Report?
Intelligent Bio Solutions (INBS) Financial Statements
Intelligent Bio Solutions Financial Overview
Intelligent Bio Solutions's market cap is currently $5.84M. The company's EPS TTM is $-9.46; its P/E ratio is -0.19; Intelligent Bio Solutions is scheduled to report earnings on November 5, 2026, and the estimated EPS forecast is $-1.31. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.22M | $ 3.05M | $ 3.11M | $ 1.26M | $ 0.00 |
| Gross Profit | $ 2.05M | $ 1.25M | $ 1.43M | $ 326.67K | $ 0.00 |
| Operating Income | $ -12.61M | $ -10.64M | $ -10.28M | $ -12.60M | $ -8.34M |
| EBITDA | $ -11.29M | $ -9.21M | $ -8.81M | $ -9.47M | $ -8.33M |
| Net Income | $ -12.43M | $ -10.57M | $ -10.16M | $ -10.63M | $ -8.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.99M | $ 1.02M | $ 6.30M | $ 1.54M | $ 8.28M |
| Total Assets | $ 11.94M | $ 8.25M | $ 13.78M | $ 10.35M | $ 12.35M |
| Total Debt | $ 1.82M | $ 281.81K | $ 1.15M | $ 1.92M | $ 0.00 |
| Net Debt | $ -2.17M | $ -738.10K | $ -5.16M | $ 378.05K | $ -8.24M |
| Total Liabilities | $ 6.65M | $ 5.44M | $ 5.60M | $ 6.67M | $ 5.81M |
| Stockholders' Equity | $ 5.51M | $ 3.00M | $ 8.33M | $ 3.80M | $ 6.62M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.05M | $ -9.91M | $ -9.79M | $ -7.88M | $ -3.74M |
| Operating Cash Flow | $ -11.93M | $ -9.68M | $ -9.57M | $ -7.38M | $ -3.36M |
| Investing Cash Flow | $ -85.57K | $ -231.84K | $ -221.43K | $ -694.14K | $ -880.22K |
| Financing Cash Flow | $ 14.98M | $ 4.60M | $ 14.56M | $ 1.44M | $ 0.00 |
Currency in USD